Survey canvases views on Falsified Medicines Directive

Published: 1-Jul-2013
Packaging

Domino invites the industry to share its opinions on the potential impact of the legislation


With the aim of finding out what pharmaceutical manufacturers really think about the potential impact of the Falsified Medicines Directive (FMD), Domino Printing Sciences’ Life Sciences Division has launched The Big Serialisation Survey.

The survey will assess the industry’s view on how the legislation will affect both generic and research-based companies, and also ask respondents who they think should fund the data repository – the Marketing Authorisation Holder or the Manufacturing Authorisation Holder. It will also address the debate over whether the FMD will enhance or impede Overall Equipment Effectiveness.

‘Through our conversations with our customers, partners and industry bodies we have found that the FMD has been causing lots of debate since it was first announced,’ says Craig Stobie, global life sciences sector manager at Domino Printing Sciences.

‘We thought it would be a great idea for manufacturers and other industry players to see what their peers think about the impending challenges, and so the idea of The Big Serialisation Survey was born. We’re really looking forward to seeing the results and sharing them with the pharmaceutical community.’

Take part in the survey

See more

You may also like

Packaging

Are your industry inks as compliant as you think? Be audit-ready, every time

Read more
As global regulations around product packaging tighten and compliance audits become more frequent, Domino Printing Sciences (Domino) is highlighting the critical importance of ink safety

Trending Articles

  1. ProMach Pharma presents new equipment at Pack Expo Las Vegas Several new systems will be on exhibit for the first time, alongside other advanced processing and packaging equipment for pharmaceuticals, biopharmaceuticals, nutraceuticals, medical devices and more
  2. Aenova Group In Europe and worldwide, Aenova is one of the leading contract development and manufacturing organisations (CDMO). The range of services covers the entire value chain of development and production of all common dosage forms (solid, semi-solid and liquid, sterile and non-sterile; high potency and low dosage) and product groups in drugs and food supplements for human and animal health
  3. Intranasal GLP-1 medication from Orexo shows positive results in preclinical trial Orexo's AmorphOX technology had positive results when compared against oral and injectable formulations in the study
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    From approval to access: the strategic role of packaging in drug launch success In today’s increasingly complex pharmaceutical landscape, securing regulatory approval is only one milestone on the journey to market
  5. SGD Pharma acquires Alphial Srl in a strategic step forward SGD Pharma is pleased to announce an agreement with Italian Private Equity firm Entangled Capital to acquire Alphial Srl, a leading producer of tubular vials and ampoules headquartered in Italy

Upcoming event

Enhancing probiotic stability through smarter formulation and packaging strategies

18 September 2025 | Virtual See all

You may also like

Packaging

Are your industry inks as compliant as you think? Be audit-ready, every time

As global regulations around product packaging tighten and compliance audits become more frequent, Domino Printing Sciences (Domino) is highlighting the critical importance of ink safety
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Environmental sustainability in manufacturing: aligning commitments

As the global focus on environmental sustainability intensifies, the manufacturing industry finds itself at a critical juncture. Worldwide, the industry is a significant contributor to greenhouse gas (GHG) emissions, accounting for roughly a quarter of global emissions
Packaging

New Domino Mx-Series labelling machines

Domino’s new print and apply labellers automate traceability coding for enhanced supply chain visibility
Manufacturing

Domino invests in end-to-end UV digital inkjet manufacturing

Domino Printing Sciences has revealed a strategic investment boost of £6.6m to its digital printing inks manufacturing capacity for better supply chain scalability and pharma labels
Packaging

Pharmaceuticals: Are you prepared for the 2D code sunrise?

International standards organisation GS1 is preparing to transition away from 1D barcodes to a new 2D barcode format, the GS1 Digital Link, with a push planned for 2027. Domino Printing Sciences. reveals what this new barcode standard means for manufacturers and provides advice on how to prepare for the 2027 sunrise date. Lee Metters and James Cutforth from Domino explain
Packaging

Individual dose identification: coding and marking for the new dimension in patient health and safety

On a global level, medication errors are one of the leading causes of avoidable harm in healthcare worldwide. It is estimated that the total annual cost for medication errors is $42 billion; some 5% of all patients admitted to hospital experience a medication error and an average hospital will have one medication error every 23 hours or every 20 admissions
Packaging

Serialisation beyond compliance: the gateway to competitive differentiation

Product-level serialisation has historically been associated with compliance mandates within highly regulated industries such as pharmaceuticals, medical devices and tobacco; its central premise was to prevent counterfeit goods from entering these markets
Subscribe now